株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

EpiCast Report:子宮内膜症の疫学予測

EpiCast Report: Endometriosis - Epidemiology Forecast to 2025

発行 GlobalData 商品コード 284134
出版日 ページ情報 英文 56 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.83円で換算しております。
Back to Top
EpiCast Report:子宮内膜症の疫学予測 EpiCast Report: Endometriosis - Epidemiology Forecast to 2025
出版日: 2016年11月01日 ページ情報: 英文 56 Pages
概要

世界の主要6ヶ国(米国、フランス、ドイツ、イタリア、スペイン、英国)における子宮内膜症の発症件数は、2012年の566万件から、2022年には586万件まで増加する(年間平均増加率3.4%)と予測されています。

当レポートでは、世界の主要6ヶ国における子宮内膜症について取り上げ、危険因子の概要と世界の動向、疫学予測、疫学レポート、疾患動向の分析を提供して、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 疫学

  • 疾患の背景
  • 危険因子と併存疾患
    • 家族歴:子宮内膜症のリスクの強力な予測因子
    • 遅発初経:子宮内膜症の発症から女性を守る
    • 経産回数:多い場合は子宮内膜症のリスクが減少
  • 世界の動向
    • 米国
    • EU5ヶ国
  • 予測手法
    • 利用した情報源
    • 利用しなかった情報源
    • 予測の前提条件と手法
  • 子宮内膜症の疫学予測
    • 診断された有病件数
    • 年齢階級別有病件数
    • 年齢調整有病率
    • 診断された有病件数:段階別
  • 議論
    • 疫学予測の考察
    • 分析の限界
    • 分析の強み

第4章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHCER129-16

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding, and infertility. Endometriosis has the potential to disrupt the quality of life of women, leading to emotional distress, loss of work productivity, physical limitations, and social withdrawal.

This report also provides diagnosed incident and prevalent cases of endometriosis segmented by laparoscopy confirmation status (laparoscopy-confirmed or suspected without laparoscopy). The laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further classified according to endometriosis staging system developed by the American Society for Reproductive Medicine (ASRM) into stage I (minimal), stage II (mild), stage III (moderate), and stage IV (severe). In addition, the laparoscopy-confirmed diagnosed prevalent cases of endometriosis are segmented by phenotypes into superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deeply infiltrating endometriosis (DIE). The laparoscopy-confirmed diagnosed incident and laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further segmented by age.

In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed incident cases of endometriosis will increase from 251,010 cases in 2015 to 253,620 cases in 2025 at an Annual Growth Rate (AGR) of 0.10%. In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed prevalent cases of endometriosis will increase from 6,160,839 cases in 2015 to 6,217,079 cases in 2025 at an AGR of 0.09%.

GlobalData epidemiologists utilized comprehensive, country-specific data from peer-reviewed journal articles, and primary research to arrive at a meaningful, in-depth analysis and forecast for laparoscopy-confirmed diagnosed incident cases of endometriosis, as well as laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Finally, the same forecast methodology was used across the 7MM, thereby allowing for meaningful global comparisons of laparoscopy-confirmed diagnosed incident cases, and laparoscopy-confirmed diagnosed prevalent cases of endometriosis across these markets.

Scope

  • The Endometriosis EpiCast Report provides an overview of the risk factors and global trends of endometriosis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the laparoscopy-confirmed diagnosed incident cases of endometriosis and a 10-year forecast of laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Additional segmentations of patient populations are also available.
  • The endometriosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Endometriosis EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global endometriosis market.
  • Quantify patient populations in the global endometriosis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for endometriosis therapeutics in each of the markets covered.
  • Identify the distribution of endometriosis prevalent cases by phenotypes and stage.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Epidemiology

  • 2.1. Disease Background
  • 2.2. Risk Factors and Comorbidities
  • 2.3. Global Trends
    • 2.3.1. US
    • 2.3.2. 5EU
    • 2.3.3. Japan
  • 2.4. Forecast Methodology
    • 2.4.1. Sources Used Tables
    • 2.4.2. Forecast Assumptions and Methods
    • 2.4.3. Sources Not Used
  • 2.5. Epidemiological Forecast for Endometriosis (2015-2025)
    • 2.5.1. Diagnosed Incident Cases
    • 2.5.2. Diagnosed Prevalent Cases
  • 2.6. Discussion
    • 2.6.1. Epidemiological Forecast Insight
    • 2.6.2. Limitations of the Analysis
    • 2.6.3. Strengths of the Analysis

3. Appendix

  • 3.1. Bibliography
  • 3.2. Physicians and Specialists Included in this Study
  • 3.3. About the Authors
    • 1.1.1. Epidemiologists
    • 3.3.1. Reviewers
    • 3.3.2. Global Director of Therapy Analysis and Epidemiology
  • 3.4. About GlobalData
  • 3.5. About EpiCast
  • 3.6. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Endometriosis
  • Table 2: Stages of Endometriosis According to the American Society for Reproductive Medicine Criteria
  • Table 3: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Incident Cases of Endometriosis
  • Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Prevalent Cases of Endometriosis
  • Table 5: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the ASRM Stages I-IV
  • Table 6: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the Phenotype
  • Table 7: Sources Used to Forecast Laparoscopy Confirmation Status for Diagnosed Incident Cases and Diagnosed Prevalent Cases of Endometriosis
  • Table 8: 7MM, Sources Not Used in Epidemiological Analysis of Endometriosis
  • Table 9: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
  • Table 10: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Women, N (Row %), 2015
  • Table 11: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
  • Table 12: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N (Row %), 2015
  • Table 13: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2016

List of Figures

  • Figure 1: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
  • Figure 2: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis by Age Group, Women, N, 2015
  • Figure 3: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Incidence of Endometriosis (Cases per 100,000 Population), Ages 12-54 Years, Women, 2015
  • Figure 4: 7MM, Diagnosed Incident Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015
  • Figure 5: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
  • Figure 6: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N, 2015
  • Figure 7: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Prevalence of Endometriosis (%), Ages 12-54 Years, Women, 2015
  • Figure 8: 7MM, Diagnosed Prevalent Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015
  • Figure 9: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by ASRM Disease Stages, Ages 12-54 Years, Women, N, 2015
  • Figure 10: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by Phenotype, Ages 12-54 Years, Women, N, 2015
Back to Top